NovaBridge Biosciences
Organization details
- Legal name
- NovaBridge Biosciences
- Former names
- I-Mab
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Rockville
- Headquarters state / province
- Maryland
- Headquarters country
- China
- Fiscal year end
- December
- Ticker symbol
- NBP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001778016
Board of directors
-
Chun Kwok Alan Au · DirectorSince 2026
-
Conor Chia-hung Yang · DirectorSince 2026
-
Emmett Cunningham · DirectorSince 2026
-
Ian Ying Woo · DirectorSince 2026
-
Martin William Dewhurst · DirectorSince 2026
-
Robert A. Lenz · DirectorSince 2026
-
Sean Wuxiong Cao · Director · Chief Bus. Development OfficerSince 2026
-
Srishti Gupta · Director · Chief Executive OfficerSince 2026
-
Wei Fu · DirectorSince 2026
-
Xi-Yong Fu · Director · See RemarksSince 2026
-
Xin Liu · DirectorSince 2026
Chief executives
Board connections
4 of this board's directors also sit on 5 other boards. 3 are in the same sector.
- via Conor Chia-hung Yang
-
Invivyd Inc. Same sectorvia Srishti Gupta
-
LB Pharmaceuticals Inc Same sectorvia Robert A. Lenz
-
Turn Therapeutics Inc. Same sectorvia Martin William Dewhurst
- via Conor Chia-hung Yang
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $577,300
- 1 purchase by 1 insider
- Sold, last 12 months
- $154,273
- 7 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2026 | Ian Ying Woo Director | Option exercise | +13,271 | — | — |
| Sep 18, 2026 | Dennis Phillip Andrew Officer (Chief Medical Officer) | Open-market sale | −8,209 | $0.71 | $5,828 |
| Sep 17, 2026 | Dennis Phillip Andrew Officer (Chief Medical Officer) | Option exercise | +23,695 | — | — |
| Sep 9, 2026 | Sean Wuxiong Cao Officer (Chief Bus. Development Officer) | Open-market sale | −107,978 | $0.74 | $79,904 |
| Sep 3, 2026 | Sean Wuxiong Cao Officer (Chief Bus. Development Officer) | Option exercise | +235,136 | — | — |
| Sep 3, 2026 | Sean Wuxiong Cao Officer (Chief Bus. Development Officer) | Option exercise | +104,236 | — | — |
| Aug 31, 2026 | Xu Cong Claire Officer (EVP, Clinical Development) | Open-market sale | −3,282 | $0.79 | $2,593 |
| Aug 30, 2026 | Xu Cong Claire Officer (EVP, Clinical Development) | Option exercise | +9,382 | — | — |
| Aug 22, 2026 | Robert A. Lenz Director | Option exercise | +17,218 | — | — |
| Jul 6, 2026 | Xu Cong Claire Officer (SVP, Clinical Development) | Open-market sale | −4,485 | $0.89 | $3,992 |
| Jul 4, 2026 | Xu Cong Claire Officer (SVP, Clinical Development) | Option exercise | +12,432 | — | — |
| Jun 18, 2026 | Dennis Phillip Andrew Officer (Chief Medical Officer) | Open-market sale | −8,494 | $0.66 | $5,606 |
| Jun 17, 2026 | Dennis Phillip Andrew Officer (Chief Medical Officer) | Option exercise | +23,695 | — | — |
| Jun 1, 2026 | Xu Cong Claire Officer (SVP, Clinical Development) | Open-market sale | −3,494 | $3.94 | $13,766 |
| May 30, 2026 | Xu Cong Claire Officer (SVP, Clinical Development) | Option exercise | +9,382 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about NovaBridge Biosciences
Who is the CEO of NovaBridge Biosciences?
Srishti Gupta has been NovaBridge Biosciences's Chief Executive Officer since July 2026.
How many directors are on NovaBridge Biosciences's board?
NovaBridge Biosciences's board has 11 directors: Chun Kwok Alan Au, Conor Chia-hung Yang, Emmett Cunningham, Ian Ying Woo, Martin William Dewhurst, Robert A. Lenz, Sean Wuxiong Cao, Srishti Gupta, Wei Fu, Xi-Yong Fu and 1 other.
Are NovaBridge Biosciences insiders buying or selling shares?
Over the last 12 months, NovaBridge Biosciences insiders bought $577,300 of shares in 1 purchase and sold $154,273 of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="novabridge-biosciences"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.